Choroidal concentration of interferon after retrobulbar injection

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 13, 1996, Pages 2768-2771

  Lincoff, Harvey ^a,c   Stanga, Paulo ^a   Movshovich, Alex ^a   Palleroni, Alicia ^b   Madjarov, Bojidar ^a   Rivera, Rafael ^a   Silverman, Ronald ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

balloon; interferon; macular degeneration; retrobulbar catheter; subretinal neovascularization

Indexed keywords

RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOROID; DRUG BLOOD LEVEL; DRUG DIFFUSION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETINA MACULA DEGENERATION; RETROBULBAR DRUG ADMINISTRATION; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; BIOLOGICAL AVAILABILITY; CHOROID; DRUG ADMINISTRATION ROUTES; FEMALE; INJECTIONS; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2A; MALE; ORBIT; RABBITS;

EID: 0030458384     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Fung WE. Interferon a-2a for treatment of age-related macular degeneration. Am J Ophthalmol. 1991; 112:349-350. Letter.
2. Guyer DR, Adamis AP, Gragoudas ES, et al. Systemic antiangiogenic therapy for choroidal neovascularization: What is the role of interferon alpha? Arch Ophthalmol. 1992; 110:1383-1384.
3. Guyer DR, Tiedman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol. 1993; 111:350-356.
4. Thomas MS, Ibaniex HE. Interferon alpha-2a in the treatment of sufboveal choroidal neovascularization. Am J Ophthalmol. 1993; 115:563-568.
5. Tholen A, Kain H, Messmer E. Treatment of age-associated macular degeneration with interferon alpha 2-a. Ophthalmologe. 1193; 90:279-282.
6. Poliner LS, Tornambe PE, Michelson PE, Heitzmann JE. Interferon alpha-2a for subfovelar neovascularization in age-related macular degeneration. Ophthalmology. 1993; 100:1417-1424.
7. Gillies MC, Sarkds JP, Beaumont PE, et al. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha 2-a and alpha 2-b. Br J Ophthalmol. 1993; 77:759-765.
8. Kirkpatrick JNP, Dick AD, Forrester JV. Clinical experience with interferon alpha 2-a for exudative age related macular degeneration. Br J Ophthalmol. 1993; 77:766-770.
9. Staehlin T, Hobbs DS, Kung HF, et al. Purification and characterization of recombinant human leukocyte interferon (INF-rA) with monoclonal antibodies. J Biol Chem. 1981; 256:9750-9754.
10. Rubenstein S, Familletti PC, Pestka S. Convenient assay for interferons. J Virol. 1981; 37:755-758.
11. Edelhauser H, Maren T. Permeability of human cornea and sciera to sulfonamide carbonic anhydrase inhibitors. Arch Ophthalmol. 1988; 106:1110-1116.